tiprankstipranks
Trending News
More News >
CareTrust REIT (CTRE)
:CTRE
Advertisement

CareTrust REIT (CTRE) AI Stock Analysis

Compare
603 Followers

Top Page

CTRE

CareTrust REIT

(NYSE:CTRE)

Rating:80Outperform
Price Target:
$39.00
▲(15.04% Upside)
CareTrust REIT's overall stock score of 80 reflects its strong financial performance, strategic growth initiatives, and positive earnings outlook. The company's robust profitability and efficient cash flow management are significant strengths. However, high valuation metrics and potential regulatory risks are areas to watch.
Positive Factors
Earnings Growth
The acquisition of Care REIT diversifies CTRE's portfolio and strengthens earnings growth by expanding into the UK and reducing US Medicaid exposure.
Financial Impact
CTRE expects the acquisition to be accretive by 5.9% to normalized FFO.
Strategic Expansion
The strategic expansion in the UK is viewed positively.
Negative Factors
Acquisition Uncertainty
The acquisition is contingent on a shareholder vote and could be terminated if not completed by July 9, 2025, creating uncertainty.
Earnings Expectations
Normalized FFO of $0.43 per share missed the Street's expectation of $0.45.
Guidance Concerns
FAD guidance was increased by 1.7%, but it remains below the Street's expectations.

CareTrust REIT (CTRE) vs. SPDR S&P 500 ETF (SPY)

CareTrust REIT Business Overview & Revenue Model

Company DescriptionCareTrust REIT (CTRE) is a real estate investment trust that focuses on the ownership and management of senior housing and healthcare properties across the United States. The company primarily invests in skilled nursing facilities, assisted living facilities, and other healthcare-related properties, catering to the growing demand for senior care services. CareTrust REIT aims to provide stable returns to its investors by acquiring and leasing properties to experienced operators, while also ensuring high-quality care for residents.
How the Company Makes MoneyCareTrust REIT generates revenue primarily through long-term leases with skilled nursing and senior housing operators. The company acquires properties and then leases them to operators under triple-net lease agreements, where the operators are responsible for property expenses such as maintenance, taxes, and insurance. This structure allows CareTrust to earn steady rental income while minimizing its operational liabilities. Additionally, CareTrust may benefit from rent escalators built into its leases, which provide incremental revenue growth over time. Significant partnerships with well-established healthcare operators enhance its portfolio's stability and performance, contributing to consistent cash flow and dividends for shareholders.

CareTrust REIT Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: 3.83%|
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
The earnings call highlighted significant achievements in investment growth, revenue increases, and strategic market expansion, particularly in the UK. However, there are some concerns about increased expenses and potential future regulatory risks. Overall, the company's strong performance and strategic growth initiatives present a positive outlook.
Q2-2025 Updates
Positive Updates
Record Investment and Revenue Growth
CareTrust REIT closed approximately $1.1 billion of investments in Q2 2025, marking a significant achievement. Total revenues increased by 63.3% year-over-year, driven by key acquisitions, including Care REIT.
Increase in Dividends and Earnings
The company raised its quarterly dividend by 15.5% compared to the previous year. Normalized FFO per share rose by 19% and normalized FAD per share by 16% year-over-year.
Expansion into the UK Market
Successfully entered the UK care home market with the acquisition of Care REIT, diversifying their geographic presence and operator relationships.
Strong Liquidity and Low Leverage
The company maintains strong liquidity with $1.14 billion available under its revolver and a net debt to annualized normalized EBITDA of 2x.
Negative Updates
Increased G&A Expenses
General and administrative expenses are expected to be between $48 million to $52 million, which includes about $12 million of stock compensation.
Potential Regulatory Risks
Concerns were raised about future regulatory and reimbursement pressures due to potential budget deficits and policy changes.
Company Guidance
During the second quarter of 2025, CareTrust REIT reported significant growth in investments and financial performance. The company closed on approximately $1.1 billion of investments, including a key acquisition of Care REIT, marking a total of $2.7 billion in investments over the past 18 months—surpassing the total investments made in the prior eight years. This strategic expansion contributed to a 63.3% increase in total revenues compared to the prior year quarter. Additionally, normalized Funds from Operations (FFO) per share grew by 19% and normalized Funds Available for Distribution (FAD) per share by 16%. CareTrust also increased its quarterly dividend by 15.5% year-over-year, maintaining a comfortable payout ratio. The company's pipeline remains robust at approximately $600 million, primarily focused on skilled nursing facilities, with a strong presence in both the U.S. and U.K. markets. Looking forward, CareTrust raised its full-year guidance for normalized FFO and FAD per share to $1.77 to $1.79, supported by a strong balance sheet, low leverage, and significant liquidity.

CareTrust REIT Financial Statement Overview

Summary
CareTrust REIT displays a strong financial profile with robust profitability and consistent revenue growth. The income statement highlights excellent profit margins, while the balance sheet shows financial stability with a strong equity base. The cash flow statement indicates efficient cash generation and management. However, rising debt levels warrant monitoring.
Income Statement
85
Very Positive
CareTrust REIT demonstrates strong income statement metrics with a solid gross profit margin and consistent revenue growth. The TTM data highlights a gross profit margin of 94.62% and a net profit margin of 65.78%, indicating excellent profitability. Revenue has grown from $187.51 million in 2022 to $246.41 million in TTM 2025, reflecting a robust growth rate. The company also maintains healthy EBIT and EBITDA margins, at 55.15% and 101.80%, respectively. Overall, the income statement reflects a strong financial performance with stable and growing profitability.
Balance Sheet
78
Positive
The balance sheet of CareTrust REIT reveals financial stability with a manageable debt-to-equity ratio of 0.28 in TTM 2025. The equity ratio stands at 75.36%, indicating a strong equity position relative to total assets. Return on equity is impressive at 5.54%, showcasing efficient utilization of equity to generate profits. However, the increasing total debt from $545.59 million in 2020 to $822.15 million in TTM 2025 presents a potential risk if not managed carefully. Overall, the balance sheet reflects a solid financial position with a strong equity base but a rising debt trend that warrants monitoring.
Cash Flow
82
Very Positive
CareTrust REIT shows a positive cash flow scenario with a substantial operating cash flow of $266.81 million in TTM 2025, indicating strong cash generation capability. The free cash flow growth rate from 2024 to TTM 2025 is 8.75%, reflecting a healthy increase. The operating cash flow to net income ratio is 1.65, and the free cash flow to net income ratio is 1.58, both indicating efficient cash flow management relative to earnings. The cash flow analysis highlights robust cash generation and efficient handling of operating activities, contributing to overall financial strength.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue303.47M228.26M217.77M187.51M190.19M175.69M
Gross Profit268.17M214.71M208.18M178.13M186.62M170.98M
EBITDA306.53M211.54M145.80M162.81M161.96M157.38M
Net Income219.74M125.08M53.73M42.87M48.30M57.21M
Balance Sheet
Total Assets4.66B3.44B2.08B1.62B1.64B1.50B
Cash, Cash Equivalents and Short-Term Investments306.05M213.82M294.45M13.18M19.89M18.92M
Total Debt0.00396.93M595.60M719.50M673.40M545.59M
Total Liabilities1.33B507.63M666.12M771.41M725.09M589.42M
Stockholders Equity3.30B2.91B1.42B849.37M915.76M914.14M
Cash Flow
Free Cash Flow301.10M236.20M143.79M137.12M150.86M137.44M
Operating Cash Flow314.61M244.25M154.77M144.41M156.87M145.74M
Investing Cash Flow-1.86B-1.51B-267.81M-127.40M-192.63M-41.58M
Financing Cash Flow1.36B1.19B394.32M-23.73M36.74M-105.56M

CareTrust REIT Technical Analysis

Technical Analysis Sentiment
Positive
Last Price33.90
Price Trends
50DMA
30.80
Positive
100DMA
29.51
Positive
200DMA
28.37
Positive
Market Momentum
MACD
0.81
Negative
RSI
76.97
Negative
STOCH
86.09
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTRE, the sentiment is Positive. The current price of 33.9 is above the 20-day moving average (MA) of 32.12, above the 50-day MA of 30.80, and above the 200-day MA of 28.37, indicating a bullish trend. The MACD of 0.81 indicates Negative momentum. The RSI at 76.97 is Negative, neither overbought nor oversold. The STOCH value of 86.09 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CTRE.

CareTrust REIT Risk Analysis

CareTrust REIT disclosed 41 risk factors in its most recent earnings report. CareTrust REIT reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CareTrust REIT Peers Comparison

Overall Rating
UnderperformOutperform
Sector (71)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$7.47B28.288.36%3.69%50.84%104.44%
77
Outperform
$3.54B23.8410.49%4.82%6.87%7.23%
74
Outperform
$4.43B24.286.66%6.50%6.89%240.70%
72
Outperform
$6.90B-1.51%2.47%11.62%
71
Outperform
¥233.02B14.8310.65%3.47%19.64%27.23%
61
Neutral
$5.79B-7.59%7.10%-7.16%23.40%
51
Neutral
$2.43B-25.97%7.90%27.66%18.03%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CTRE
CareTrust REIT
33.90
6.92
25.65%
NHI
National Health Investors
74.66
3.80
5.36%
SBRA
Sabra Healthcare REIT
18.46
3.56
23.89%
MPW
Medical Properties
4.05
-0.29
-6.68%
HR
Healthcare Realty Trust
16.47
0.20
1.23%
AHR
American Healthcare REIT, Inc.
40.45
21.91
118.18%

CareTrust REIT Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
CareTrust REIT Completes Major Stock Issuance
Positive
Aug 14, 2025

On August 12, 2025, CareTrust REIT, Inc. entered into an underwriting agreement with major financial institutions to sell 20,000,000 shares of its common stock at $32.00 per share, with an option for an additional 3,000,000 shares, which was fully exercised the next day. The issuance of these shares, completed on August 14, 2025, was part of a strategic move to enhance the company’s financial positioning and potentially expand its operations within the healthcare real estate sector.

The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.

Private Placements and FinancingM&A TransactionsBusiness Operations and StrategyFinancial Disclosures
CareTrust REIT Expands with $1.1 Billion Investments
Positive
Aug 6, 2025

CareTrust REIT reported its second quarter 2025 results, highlighting significant investments totaling $1.1 billion, including the acquisition of Care REIT plc, and an upsized credit facility. The company achieved a net income of $68.5 million and maintained a strong financial position with a net debt-to-annualized normalized run rate EBITDA of 2.0x. CareTrust also increased its 2025 financial guidance, projecting higher net income and FFO per share, while maintaining a quarterly dividend payout ratio of approximately 78%. The strategic acquisition of Care REIT marked CareTrust’s entry into the UK market, broadening its operator bench and diversifying its asset mix, payor base, and geographic reach.

The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.

Private Placements and FinancingBusiness Operations and Strategy
CareTrust REIT Secures $500 Million Term Loan Facility
Positive
Jun 2, 2025

On May 30, 2025, CareTrust REIT, Inc. entered into an amendment to its credit and guaranty agreement, introducing a $500 million unsecured term loan facility alongside its existing $1.2 billion revolving credit facility. This move is expected to help the company pay off existing debt, fund acquisitions, and support general corporate purposes, potentially enhancing its financial flexibility and positioning in the healthcare real estate market.

The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.

Business Operations and Strategy
CareTrust REIT Updates Investor Presentation
Neutral
May 29, 2025

CareTrust REIT, Inc. has released an updated investor presentation available on their website. The company clarifies that this update is not mandated by securities laws and does not include undisclosed material investor information.

The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 15, 2025